Results from the Angina Prognosis study in Stockholm. Circulation. 1997;95:2380 6. 753. Anand SS, Yusuf S. Oral anticoagulants in patients with coronary artery disease. J Am Coll Cardiol. 2003;41:62S 9S. 754. Boekholdt SM, Bijsterveld NR, Moons AH, et al. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation. 2001;104: 3063 8. 755. Martini CH, Doggen CJ, Cavallini C, et al. No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors. J Thromb Haemost. 2005; 3:177 9. 756. No evidence of association between prothrombotic gene poly- morphisms and the development of acute myocardial infarction at a young age. Circulation. 2003;107:1117 22. 757. Kernis SJ, Harjai KJ, Stone GW, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after suc- cessful primary angioplasty? J Am Coll Cardiol. 2004;43:1773 9. 758. de Peuter OR, Lussana F, Peters RJ, et al. A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure. Neth J Med. 2009;67:284 94. 759. Freemantle N, Cleland J, Young P, et al. beta Blockade after myo- cardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730 7. 760. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334: 1349 55. 761. Leizorovicz A, Lechat P, Cucherat M, et al. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies CIBIS and CIBIS II. Cardiac Insuffi- ciency Bisoprolol Study. Am Heart J. 2002;143:301 7. 762. Poole-Wilson PA, Swedberg K, Cleland JG, et al. 